Amino Levulinic Acid (ALA), Urine Spot

The amino levulinic acid (ALA) urine test measures the concentration of ALA in a random (spot) urine sample.

• Increased ALA concentration is associated with exposure to alcohol and a variety of other agents.

• The amino levulinic acid (ALA) urine spot test is typically conducted to help diagnose and monitor acute hepatic porphyrias, a group of rare inherited disorders that result from defects in the enzymes involved in the heme synthesis. Acute hepatic porphyrias include acute intermittent porphyria (AIP), hereditary coproporphyria (HCP), variegate porphyria (VP), and ALA dehydratase deficiency porphyria (ADP). These conditions cause an accumulation of ALA and other intermediates in the liver and other tissues, leading to neurologic and psychiatric symptoms, such as abdominal pain, nausea, vomiting, constipation, muscle weakness, seizures, hallucinations, and anxiety.

• The test may also be used to screen for lead poisoning, a condition caused by exposure to high levels of lead, a toxic metal that can damage various organs and systems in the body. Lead poisoning can interfere with the activity of ALA dehydratase, an enzyme that converts ALA to another intermediate called porphobilinogen (PBG), resulting in increased levels of ALA in the urine.

• The test can also help evaluate other conditions that affect the heme synthesis or metabolism, such as hereditary tyrosinemia type I, a disorder that causes a deficiency of fumarylacetoacetate hydrolase, an enzyme that breaks down tyrosine, an amino acid. Hereditary tyrosinemia type I can cause increased levels of ALA and other metabolites in the urine.

• When a patient presents with symptoms or signs of acute hepatic porphyria, such as abdominal pain, nausea, vomiting, constipation, muscle weakness, seizures, hallucinations, or anxiety.

• To screen for lead poisoning in people who have been exposed to high levels of lead or have symptoms such as headache, fatigue, irritability, memory loss, anemia, or neuropathy.

• To diagnose or rule out hereditary tyrosinemia type I in infants or children who have symptoms such as failure to thrive, jaundice, bleeding tendency, rickets, or liver cancer. • To monitor the response to treatment and prognosis of these conditions.

An elevated quantity of amino levulinic acid (ALA) in the urine is typically observed in illnesses such acute hepatic porphyrias, lead poisoning, and hereditary tyrosinemia type I. A positive result on an ALA urine spot test may indicate these conditions.

The test typically involves a urine collection, where a patient will provide a random (spot) urine sample in a clean container. The procedure is relatively simple and noninvasive.

Patients may be advised to follow specific instructions before the test, such as avoiding certain foods or medications that can affect the levels of ALA in the urine. Some examples are alcohol, barbiturates, oral contraceptives, sulfonamides, and acetaminophen. It’s essential to follow your healthcare provider’s guidance to ensure accurate test results.

• Porphobilinogen (PBG) urine spot test: To measure the levels of PBG in the urine, another intermediate compound in the heme synthesis. PBG is also increased in acute hepatic porphyrias and lead poisoning.

• Porphyrins urine test: To measure the levels of porphyrins in the urine, the final products of the heme synthesis. Porphyrins are increased in various types of porphyrias, such as acute hepatic porphyrias, cutaneous porphyrias, and erythropoietic porphyrias.

• Genetic testing for acute hepatic porphyrias: To identify the specific type and number of mutations in the genes that encode the enzymes involved in the heme synthesis. Genetic testing can help confirm the diagnosis of acute hepatic porphyrias and can be useful for at-risk family screening.

• Blood lead test: To measure the level of lead in the blood, which is an indicator of lead exposure and poisoning.

• Liver function tests: To assess the health and function of the liver, which produces ALA and other proteins.

• Kidney function tests: To assess the health and function of the kidneys, which excrete ALA and other metabolites.

• ALA urine test • Aminolevulinic acid urine test

The ALA urine test is a diagnostic tool that measures the levels of delta-aminolevulinic acid (ALA) in your urine. It helps diagnose conditions such as porphyrias, lead poisoning, and aminolevulinic acid dehydratase deficiency.

Yes, many diagnostic centres in India offer free home sample collection services, including Metropolis Healthcare for the ALA urine test, making it convenient for you to get tested.

Normal levels of ALA in urine typically range from 0 to 7 mg per 24 hours. Levels higher than this may indicate an underlying condition.

The ALA urine test is used to diagnose and screen for conditions such as porphyrias, lead poisoning, aminolevulinic acid dehydratase deficiency, and hereditary tyrosinemia.

The frequency of ALA urine testing depends on your clinical indication and condition. Your healthcare provider will recommend the appropriate testing schedule based on your specific needs.

There is no specific time requirement for the ALA urine test. For a 24-hour urine collection, you can start at any convenient time, such as 8 AM, and complete it 24 hours later.

No, fasting is not required for the ALA urine test. However, you should avoid consuming alcohol for at least 24 hours before the test.

Yes, when preparing for an ALA urine test, protect your urine sample from light, refrigerate or freeze it as necessary, and consult your doctor about any medications that might interfere with the test results.

The primary parameter measured in the ALA urine test is the concentration of delta-aminolevulinic acid (ALA) in your urine. Sometimes, urine porphobilinogen and total porphyrins may also be tested as part of the diagnostic process.

An ALA urine test should be done when your healthcare provider suspects conditions such as porphyrias, lead poisoning, or aminolevulinic acid dehydratase deficiency based on your clinical symptoms and other diagnostic criteria.

Collecting a random urine sample for the ALA urine test takes minimal time, while a 24-hour urine collection takes 24 hours to complete. The actual testing process may take a few days, but results are typically available within 2-3 working days.

Reports for the ALA urine test are usually available within a week based on the day/time the sample is collected and processed.